Cordycepin

N/A

Report date: 2026/01/10 20:00:10
NME

Base Information

Drug NameCordycepin
Drug Alias Name3'-deoxyadenosine虫草素冬虫夏草素蛹虫草菌素冬虫夏草菌素 +[10] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLymphopeniaLeukemia, Lymphoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesDaniscoNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital Of Soochow University
Inactive CompaniesOncovista Innovative TherapiesBoston Medical Center IncNational Cancer Institute +[4] 
Active IndicationsSolid tumoursLymphopenia
Inactive IndicationsLeukemia, LymphoidLeukemia

Other Information

ATC CodeN/A
Related LinksWikipedia